NI
72
4
MSI
72
-3
FAST
57
-3
COST
57
-6
LRCX
37
-9
HCP
56
-8
EW
32
3
CSCO
58
-2
MTCH
20
-8
DFS
64
2
TMO
42
-6
EOG
56
-2
GLW
45
-3
BMY
55
-8
DAL
84
-3
KEY
43
-3
O
17
-13
KSS
39
-7
WEC
53
5
CVX
43
-3
NI
72
4
MSI
72
-3
FAST
57
-3
COST
57
-6
LRCX
37
-9
HCP
56
-8
EW
32
3
CSCO
58
-2
MTCH
20
-8
DFS
64
2
TMO
42
-6
EOG
56
-2
GLW
45
-3
BMY
55
-8
DAL
84
-3
KEY
43
-3
O
17
-13
KSS
39
-7
WEC
53
5
CVX
43
-3
Financhill
Back

UiPath Vs. Repligen Industry Stock Comparison

Buy
76

PATH
UiPath

Last Price:
12.49
Seasonality Move:
14.76%
Sell
30

RGEN
Repligen

Last Price:
125.74
Seasonality Move:
7.3%
Buy
76
UiPath (PATH) is a Buy

Is UiPath a Buy, Sell or Hold?

  • The current UiPath [PATH] share price is $12.37. The Score for PATH is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
  • PATH is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Repligen (RGEN) is a Sell

Is Repligen a Buy, Sell or Hold?

  • The current Repligen [RGEN] share price is $124.73. The Score for RGEN is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • RGEN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PATH Stock Price Chart

What is UiPath's stock price today?

  • The UiPath share price today is $12.37
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PATH is experiencing slight selling pressure.

RGEN Stock Price Chart

What is Repligen's stock price today?

  • The Repligen share price today is $124.73
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGEN is experiencing selling pressure, which indicates risk of future bearish movement.

PATH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.13 Buy
Relative Strength Index (14 RSI): 44.85 Sell
Chaikin Money Flow: -2801285 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.36 - 13.22) Sell
Bollinger Bands (100): (11.86 - 12.94) Sell

RGEN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.46 Sell
Relative Strength Index (14 RSI): 36.22 Sell
Chaikin Money Flow: -1285419 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (134.94 - 146.38) Sell
Bollinger Bands (100): (130 - 153.64) Sell

PATH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.19 Sell
20-day SMA: 12.78 Sell
50-day SMA: 12.59 Sell
200-day SMA: 16.2 Sell
8-day EMA: 12.95 Sell
20-day EMA: 12.86 Sell
50-day EMA: 12.72 Sell
200-day EMA: 14.85 Sell

RGEN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 142.02 Sell
20-day SMA: 140.23 Sell
50-day SMA: 141.19 Sell
200-day SMA: 157.58 Sell
8-day EMA: 139.7 Sell
20-day EMA: 140.54 Sell
50-day EMA: 141.71 Sell
200-day EMA: 151.3 Sell

UiPath Earnings Growth & PATH Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.08 per share.

Repligen Earnings Growth & RGEN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.22 per share.

UiPath Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Repligen Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):